REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Reviva Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $369 K, a 616% increase year-over-year.
  • Reviva Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $3.73 M, a 1878% increase year-over-year.
  • Reviva Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.41 M, a 1831% increase from 2022.
  • Reviva Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $177 K, a 65.6% increase from 2021.
  • Reviva Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $107 K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.73 M $369 K +$318 K +616% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.41 M $391 K +$334 K +590% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 $3.08 M $350 K +$310 K +763% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.77 M $2.62 M +$2.58 M +6472% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $189 K $51.5 K +$11.8 K +29.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $177 K $56.6 K -$5.45 K -8.78% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 $182 K $40.6 K +$13 K +47.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $169 K $39.9 K +$22.8 K +133% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $146 K $39.7 K +$39.7 K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $107 K $62 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $27.6 K +$27.6 K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $17.1 K +$17.1 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.